Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival (Q56908216)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 September 1997
edit
Language Label Description Also known as
English
Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival
scientific article published on 01 September 1997

    Statements

    Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit